Inactive Instrument

Other languages Nuvo Pharmaceuticals Inc Toronto S.E.

Equities

CA67092F1045

Other languages

Unlock all the news: Be the first to know and act before the market!

Searchlight Pharma Inc. completed the acquisition of Nuvo Pharmaceuticals Inc. from Red Oak Partners, LLC and other shareholders.	13/03/23
Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare Up 88% After Entering into Definitive Agreement to be Acquired by Searchlight Pharma Inc.	28/12/22
Miravo Healthcare™ conclut une convention définitive visant son acquisition par Pharmaceutique Searchlight inc.	23/12/22
Miravo Healthcare Reports Q3 Results, Says Canadian Commercial Business Segment Continues to Grow	14/11/22
Nuvo Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22
Nuvo Pharmaceuticals Seeks Acquisitions	15/08/22
Miravo Healthcare Higher as Announces Q2 Revenue of $20.9 Million; to Wind Down Pennsaid 2% Quebec Facility	15/08/22
Nuvo Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	15/08/22
Nuvo Pharmaceuticals Inc. Appoints Anthony Snow to the Board of Directors	15/08/22
Miravo Healthcare™ Announces Appointment of Dale MacCandlish Weil to Its Board of Directors	24/05/22
Nuvo Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22
Nuvo Pharmaceuticals Inc. Provides an Update on the United States Pennsaid® 2% Business	12/05/22
Nuvo Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	28/03/22
Miravo Healthcare Announces Canadian Commercial Launch of Blexten	01/03/22
Nuvo Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/11/21
Earnings Flash (MRV) NUVO PHARMACEUTICALS Reports Q3 Revenue $17.1M	15/11/21
Nuvo Pharmaceuticals : Swings to Q2 Net Income from Year-Ago Loss; Adjusted Revenue Nears C$20 Million	09/08/21
Nuvo Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	09/08/21
Nuvo Pharmaceuticals : Q1 Loss $1.58 Per Share	17/05/21
Nuvo Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	17/05/21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Nuvo Pharmaceuticals Inc Toronto S.E.

Equities

CA67092F1045

Other languages

Filters